November 04, 2026

Low PET uptake may mask aortic sarcoma

Recurrent arterial embolization prompted surgery after imaging suggested thrombus, but definitive pathology revealed malignancy.

MDSpire News

November 03, 2026

AI may cut breast biopsy review time by 44%

A paired-reader study found that pathologists maintained high diagnostic agreement while reviewing breast biopsy slides faster with AI assistance.

MDSpire News

October 30, 2026

High TIRADS may signal cancer despite benign cytology

Patients with higher ultrasound risk classifications had about 5.7 times the adjusted odds of postoperative malignancy in a selected surgical cohort.

MDSpire News

October 30, 2026

Pedicle freezing may aid distal femur salvage

Investigators reported 90% limb preservation without nonunion, although graft resorption complicated reconstruction in skeletally immature patients.

MDSpire News

October 29, 2026

Surface EMG may restore speech after laryngectomy

Investigators converted silently articulated words into intelligible speech and recreated a patient's presurgical voice.

MDSpire News

October 29, 2026

FDA monthly preview: Key November decisions to watch

Upcoming FDA decisions span cancer, cardiovascular disease, rare genetic disorders, and more.

MDSpire News

October 27, 2026

Endometrial cancer drug cuts progression or death risk 41%

FDA grants Priority Review following improved survival versus chemotherapy in phase 3 trial.

MDSpire News

October 27, 2026

FDA expands talazoparib use in prostate cancer

The combination with enzalutamide reduced the risk of radiographic progression or death by 52% .

MDSpire News

October 26, 2026

Cryptococcal cellulitis may lead to amputation

A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination.

MDSpire News

October 23, 2026

FDA raises TMB threshold for pembrolizumab

Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.

MDSpire News